SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-045082
Filing Date
2022-04-12
Accepted
2022-04-12 16:26:34
Documents
13
Period of Report
2022-04-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2212379d1_8k.htm   iXBRL 8-K 31537
2 EXHIBIT 99.1 tm2212379d1_ex99-1.htm EX-99.1 14979
  Complete submission text file 0001104659-22-045082.txt   227826

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mxct-20220407.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mxct-20220407_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mxct-20220407_pre.xml EX-101.PRE 22593
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2212379d1_8k_htm.xml XML 3703
Mailing Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878
Business Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

IRS No.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 22822551
SIC: 8731 Services-Commercial Physical & Biological Research